SEC Form 4 · accession 0001654954-17-007835
CorMedix Inc. · CRMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mehmood Khan
Director
Period of report
Aug 14, 2017
Accepted (ET)
Aug 22, 2017 · 4:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001410098
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 14, 2017 | P | 50,000 | $0.35 | A | 50,000 | D | |
| Common Stock | Aug 15, 2017 | P | 50,000 | $0.37 | A | 100,000 | D | |
| Common Stock | Aug 16, 2017 | P | 100,000 | $0.39 | A | 200,000 | D | |
| Common Stock | Aug 17, 2017 | P | 150,000 | $0.41 | A | 350,000 | D | |
| Common Stock | Aug 18, 2017 | P | 50,000 | $0.42 | A | 400,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy Common Stock)F1 | $0.45 | holding | — | — | — | — | Jun 25, 2027 | Common Stock | 75,000 | 75,000 | D |
Explanation of responses
- F1These options were granted on 6/25/2017. These options vest 1/3 on the date of grant, 1/3 on the first anniversary of the date of grant and 1/3 on the second anniversary of the date of grant.